Epstein-Barr Virus-related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti-CD30 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Case Reports Année : 2020

Epstein-Barr Virus-related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti-CD30

, (1) , (2) , (2) , (2) , (2) , (2, 3) , (4)
1
2
3
4
Lydia Montes
  • Fonction : Auteur
Clara Yzet
Denis Chatelain
  • Fonction : Auteur
  • PersonId : 1149906
  • IdRef : 080482635
Delphine Lebon
Jean-Pierre Marolleau
  • Fonction : Auteur
  • PersonId : 887235
  • IdRef : 06981676X

Résumé

Epstein-Barr virus-related mucocutaneous ulcer lymphoma is a rare entity promoted by immunosuppression. It is less described in inflammatory bowel diseases, and mostly these are refractory diseases. CD30 acts to Epstein-Barr virus (EBV) local proliferation and thus could be an interesting target. Brentuximab vedotin could become a new helpful tool.

Dates et versions

hal-03551528 , version 1 (01-02-2022)

Identifiants

Citer

Lydia Montes, Estelle Tredez, Clara Yzet, Caroline Delette, Denis Chatelain, et al.. Epstein-Barr Virus-related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti-CD30. Clinical Case Reports, 2020, 8 (6), pp.958-961. ⟨10.1002/ccr3.2721⟩. ⟨hal-03551528⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More